Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT)

Historical Holders from Q1 2021 to Q2 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
BOLT on Nasdaq
Shares outstanding
38,512,859
Price per share
$0.34
Price from insider filings
$0.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 9.9% $1,296,343 3,812,773 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025

Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q2 0 $0 -$7,330,376 $0.34 0
2025 Q1 18,325,858 $7,330,376 -$193,088 $0.40 28
2024 Q4 18,655,032 $9,991,357 -$538,723 $0.54 36
2024 Q3 18,782,186 $12,170,936 -$2,809,769 $0.65 31
2024 Q2 22,625,730 $16,969,353 -$2,129,237 $0.75 34
2024 Q1 24,001,384 $33,602,029 -$125,442 $1.40 37
2023 Q4 24,125,809 $27,021,270 -$1,754 $1.12 38
2023 Q3 24,542,560 $25,524,580 -$666,577 $1.04 33
2023 Q2 25,066,589 $32,083,628 +$2,207,936 $1.28 39
2023 Q1 23,321,104 $32,404,117 +$3,831,681 $1.39 40
2022 Q4 20,591,605 $26,769,288 -$9,353,096 $1.30 43
2022 Q3 26,786,755 $39,646,135 -$267,805 $1.48 49
2022 Q2 26,843,538 $54,760,591 -$6,142,009 $2.04 56
2022 Q1 28,919,953 $79,256,000 -$19,556,970 $2.74 62
2021 Q4 33,601,118 $164,645,000 -$37,248,679 $4.90 58
2021 Q3 35,503,222 $449,065,381 +$27,105,726 $12.65 70
2021 Q2 33,292,492 $513,799,000 -$29,685,113 $15.46 61
2021 Q1 31,494,188 $1,036,457,376 +$1,036,457,376 $32.91 69